Group 1 - The core point of the article is the appointment of Liao Changjiang as an independent non-executive director of Bank of China Hong Kong, effective from March 11, 2026 [1] - Liao will also serve as a member of the Nomination and Remuneration Committee, Risk Committee, and Sustainability Committee [1]

Core Viewpoint - China Biologic Products (01177.HK) announced that its subsidiary, Chengdu Kanghong Pharmaceutical Group Co., Ltd., has received clinical trial approval from the National Medical Products Administration (NMPA) for TQB3205, a pan-KRAS inhibitor intended for the treatment of advanced malignant tumors [1][2] Group 1: Product Development - TQB3205 is an oral pan-KRAS inhibitor that binds with high affinity to various KRAS mutant proteins, inhibiting SOS1-mediated KRAS nucleotide exchange and blocking RAS activation, thereby effectively suppressing the proliferation of various KRAS mutant tumor cells [1] - The KRAS gene is the most frequently mutated gene in the RAS family, with approximately 30% of cancer cases globally associated with RAS gene mutations, and KRAS mutations account for 85% of all RAS mutations, prevalent in pancreatic cancer (90%), colorectal cancer (30%-50%), and non-small cell lung cancer (15%-20%) [1] Group 2: Market Need and Future Plans - Despite the approval of the KRASG12C inhibitor, Sotorasib (brand name: Anfatin), by NMPA in November 2024, the clinical demand in the KRAS field remains unmet, highlighting the urgent need for pan-KRAS inhibitors that can cover a broader range of mutation subtypes [2] - The company aims to accelerate the clinical development of TQB3205 to overcome existing treatment limitations and provide new therapeutic options for a wider range of patients with advanced malignant tumors harboring KRAS mutations [2]

公司决定行使21银河Y2发行人赎回权，即全部赎回21银河Y2。 格隆汇3月11日丨中国银河(06881.HK)公告，中国银河证券股份有限公司(以下简称"公司"或"发行人")于 2026年3月10日披露了《中国银河证券股份有限公司公开发行2021年永续次级债券(第二期)发行人不行 使续期选择权暨行使赎回权并全额兑付的公告》(公告编号：2026-023)，本公告为上述事项的提示性公 告。 公司于2021年4月21日完成中国银河证券股份有限公司公开发行2021年永续次级债券(第二期)(以下简 称"21银河Y2")的发行工作。根据《中国银河证券股份有限公司公开发行2021年永续次级债券(第二期) 募集说明书》，21银河Y2设发行人赎回权，于21银河Y2第五个和其后每个付息日，发行人有权按面值 加应付利息(包括所有递延支付的利息及其孳息)赎回21银河Y2。 公司将根据相关业务规则，做好21银河Y2后续信息披露及还本付息工作。 ...

Group 1 - Samsung's new flagship smartphone Galaxy S26 series officially launched on March 11, featuring the world's first "privacy screen" anti-peeping function and Galaxy AI in collaboration with Gemini, resulting in high pre-sale demand [1] - In South Korea, the Galaxy S26 set a record for the highest pre-sale figures in the series, with the Galaxy S26 Ultra being the most popular among consumers [1] - In the Chinese market, the rise of instant retail channels has become a significant sales trend for Samsung's new devices, with Meituan Flash Purchase being a key platform for pre-sales and first sales [1][3] Group 2 - Meituan Flash Purchase has over 1,200 authorized Samsung experience stores participating in the pre-sale and first sale, offering a rapid delivery service within 30 minutes [1] - The General Manager of Samsung's Mobile Communications Retail Division in Greater China stated that Meituan Flash Purchase became one of the top platforms for pre-sale sales of the S26 series, highlighting the surprise success of instant retail [1] - Instant retail has gained popularity in China since last year, with consumers increasingly choosing these platforms for purchasing digital appliances, prompting brands to enhance their presence in this channel [3]

Group 1 - The core strategy of the company is the launch of the "Flash Charge China" initiative, aiming to establish a total of 20,000 fast charging stations by the end of 2026 [1] - The plan includes 18,000 urban "station-in-station" setups in collaboration with operators, targeting 90% coverage within 5 kilometers in urban areas [1] - Additionally, the company plans to build 2,000 "highway stations" to cover nearly one-third of highway service areas, with an average distance of about 100 kilometers between stations [1]

Group 1 - The core point of the article is that CITIC Securities (06030.HK) will hold a board meeting on March 26, 2026, to consider and approve the audited performance for the year ending December 31, 2025, and to propose the distribution of the final dividend [1]

格隆汇3月11日丨比亚迪股份(01211.HK)公布，谨定于2026年3月27日(星期五)举行董事会会议，以考虑 及批准(其中包括)公司截至2025年12月31日止的经审核年度业绩及其发布，派发2025年度的末期股息(如 有)，以及处理其他事项(如有)。 ...

格隆汇3月11日丨比亚迪股份(01211.HK)公布，谨定于2026年3月27日(星期五)举行董事会会议，以考虑 及批准(其中包括)公司截至2025年12月31日止的经审核年度业绩及其发布，派发2025年度的末期股息(如 有)，以及处理其他事项(如有)。 ...

Group 1 - The company BYD Electronics (00285.HK) has announced a board meeting scheduled for March 27, 2026, to consider and approve its audited annual performance for the year ending December 31, 2025 [1] - The meeting will also address the distribution of the final dividend for the year 2025, if applicable, along with any other matters that may arise [1]

格隆汇3月11日丨华润置地(01109.HK)发布公告，2026年3月10日，公司作为借款人，与一家银行作为贷 款人，就金额为10亿港币的定期贷款融资，订立一份贷款融资协议。该贷款融资的最后到期日为以下日 期的较早者：(i)自该融资协议下首次被提取款项或拟被提取款项之日起计五年，及(ii)2032年6月10日。 ...